These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1173 related articles for article (PubMed ID: 23458769)

  • 1. Clinical relevance of the ESKAPE pathogens.
    Pendleton JN; Gorman SP; Gilmore BF
    Expert Rev Anti Infect Ther; 2013 Mar; 11(3):297-308. PubMed ID: 23458769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for managing today's infections.
    Carmeli Y
    Clin Microbiol Infect; 2008 Apr; 14 Suppl 3():22-31. PubMed ID: 18318876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
    Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-drug resistant ESKAPE pathogens and the uses of plants as their antimicrobial agents.
    Idris FN; Nadzir MM
    Arch Microbiol; 2023 Mar; 205(4):115. PubMed ID: 36917278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year surveillance of ESKAPE pathogens in an intensive care unit of Monterrey, Mexico.
    Llaca-Díaz JM; Mendoza-Olazarán S; Camacho-Ortiz A; Flores S; Garza-González E
    Chemotherapy; 2012; 58(6):475-81. PubMed ID: 23548324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress and challenges in implementing the research on ESKAPE pathogens.
    Rice LB
    Infect Control Hosp Epidemiol; 2010 Nov; 31 Suppl 1():S7-10. PubMed ID: 20929376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of antibiotic resistance in the intensive care unit setting.
    Petrosillo N; Capone A; Di Bella S; Taglietti F
    Expert Rev Anti Infect Ther; 2010 Mar; 8(3):289-302. PubMed ID: 20192683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview perspective of bacterial resistance.
    Furtado GH; Nicolau DP
    Expert Opin Ther Pat; 2010 Oct; 20(10):1273-6. PubMed ID: 20687782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The challenges of antimicrobial resistance in Brazil.
    Rossi F
    Clin Infect Dis; 2011 May; 52(9):1138-43. PubMed ID: 21467020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment.
    McDonald LC
    Clin Infect Dis; 2006 Jan; 42 Suppl 2():S65-71. PubMed ID: 16355319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventilator-associated pneumonia caused by ESKAPE organisms: cause, clinical features, and management.
    Sandiumenge A; Rello J
    Curr Opin Pulm Med; 2012 May; 18(3):187-93. PubMed ID: 22366995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Moet GJ; Jones RN; Biedenbach DJ; Stilwell MG; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):7-13. PubMed ID: 17059876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimicrobial resistance of Gram negative bacilli isolated from tertiary-care hospitals in Colombia].
    Briceño DF; Correa A; Valencia C; Torres JA; Pacheco R; Montealegre MC; Ospina D; Villegas MV;
    Biomedica; 2010; 30(3):371-81. PubMed ID: 21713339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bactericidal efficacy of atmospheric pressure non-thermal plasma (APNTP) against the ESKAPE pathogens.
    Flynn PB; Higginbotham S; Alshraiedeh NH; Gorman SP; Graham WG; Gilmore BF
    Int J Antimicrob Agents; 2015 Jul; 46(1):101-7. PubMed ID: 25963338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiresistant Gram-negative infections: a global perspective.
    Ho J; Tambyah PA; Paterson DL
    Curr Opin Infect Dis; 2010 Dec; 23(6):546-53. PubMed ID: 20802331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial Resistance in
    Lupo A; Haenni M; Madec JY
    Microbiol Spectr; 2018 Jun; 6(3):. PubMed ID: 30101740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriology of parapneumonic pleural effusions in an Indian hospital.
    Mohanty S; Kapil A; Das BK
    Trop Doct; 2007 Oct; 37(4):228-9. PubMed ID: 17988487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial Resistance in ESKAPE Pathogens.
    De Oliveira DMP; Forde BM; Kidd TJ; Harris PNA; Schembri MA; Beatson SA; Paterson DL; Walker MJ
    Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32404435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.